Cantimer and Advanced Instruments have signed a license and product development agreement. Under the terms of the license agreement, Advanced Instruments has received an exclusive license to Cantimer's sensor technology for select applications in the biotech market.
Cantimer and Advanced Instruments have also entered into a product development agreement for Cantimer to develop a specific sensor to integrate into Advanced Instruments’ products for in-situ monitoring of osmolality in bioreactors and fermenters.
The companies anticipate that a long term sensor supply agreement will follow the joint development effort and that developed products will be sold to end-users through Advanced Instruments’ existing commercial network.
Cantimer’s sensor platform can be adapted to detect and measure a broad array of chemical and biological compounds of interest and has application in markets as large and diverse as life science research, point-of-care diagnostics, consumer health, bio-defense and environmental monitoring.
Cantimer’s technology enables the development of simple, portable devices. In parallel to the development of its own first commercial product, a pocket device for non-invasive measurement and monitoring of changes in human hydration, the company has undertaken a number of sensor development projects for strategic partners.
John Coughlin, CEO of Advanced Instruments, said: “Monitoring osmolality is a critical control parameter in the biotech market. Traditionally this has been accomplished using discreet samples on a laboratory instrument. Cantimer’s unique sensor technology makes it possible to measure osmolality in the bioreactor and in real time, reducing the possibility of product contamination and enabling tighter product quality control. The industry has been asking for this capability for many years and we believe Cantimer’s technology will allow us to finally address their needs.”